KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub-Reference-Cited by-同舟云学术

KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub

Published:2017-09 Issue:10 Volume:20 Page:2368-2383
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Das Tirtha Kamal,Cagan Ross Leigh

Funder

NIH

Department of Defense

American Cancer Society

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference44 articles.

1. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases;Apsel;Nat. Chem. Biol.,2008

2. EGF-receptor specificity for phosphotyrosine-primed substrates provides signal integration with Src;Begley;Nat. Struct. Mol. Biol.,2015

3. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects;Beldjord;J. Clin. Endocrinol. Metab.,1995

4. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma;Boumahdi;Nature,2014

5. The Carnegie protein trap library: a versatile tool for Drosophila developmental studies;Buszczak;Genetics,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer;Cancer Letters;2024-11

2. Side Chain Investigation of Imidazopyridazine as a Hinge Binder for Targeting Actionable Mutations of RET Kinase;ACS Medicinal Chemistry Letters;2024-09-03

3. Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment;Pharmacology & Therapeutics;2024-05

4. Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer;Biomedicine & Pharmacotherapy;2024-02

5. Differences in Genomic Alterations and Accumulations of Heavy Metals Between Advanced Non-small Cell Lung Cancer Patients with and without Bone Metastasis;Journal of Cancer;2024